Companies

STRYKER CORP

SYK · CIK 0000310764 · operating

$387.46+0.36%Last updated Feb 27, 10:04 PM

Key Statistics

Valuation

Market Cap$148.28B
P/E46.07
Fwd P/E23.15
PEG
P/S5.90
P/B6.61
EV/EBITDA23.10
EV/Rev6.39

Profitability

Gross Margin64.54%
Op. Margin68.18%
Net Margin11.84%
ROE
ROA1.77%
FCF Margin59.73%

Financial Health

Current Ratio1.89
Debt/Equity
Free Cash Flow$4.28B
Div. Yield0.91%

Growth & Other

Revenue Growth11.42%
EPS Growth56.03%
Beta0.87
52W High$404.87
52W Low$329.16

About STRYKER CORP

Stryker Corporation manufactures and distributes medical devices and technologies across surgical, neurotechnology, and orthopedic applications. The company operates in approximately 61 countries through company-owned subsidiaries and branches as well as third-party dealers and distributors, serving doctors, hospitals, and healthcare facilities globally.

The MedSurg and Neurotechnology segment encompasses surgical equipment, patient safety technologies, navigation and endoscopic systems, patient handling devices, and emergency medical equipment. This segment also includes minimally invasive products for acute ischemic and hemorrhagic stroke treatment, venous thromboembolism management, and traditional brain and skull-based surgical procedures, alongside orthobiologic and biosurgery products such as synthetic bone grafts and vertebral augmentation systems. The Orthopaedics segment focuses on implants for total joint replacements in the hip, knee, shoulder, and ankle, as well as trauma and extremities surgeries. The segment also includes Mako Shoulder, an addition to the company's smart robotics platform.

Stryker employs 56,000 full-time employees and operates as a publicly traded company on the NYSE with a market capitalization of $142.6 billion. Founded in 1941 and incorporated in Michigan, the company maintains its headquarters in Portage, Michigan.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2025$2.20$2.21+56.0%
2024$1.41$1.43-52.7%
2023$2.98$3.01+102.7%
2022$1.47$1.48-15.0%
2021$1.73$1.75+16.1%
2020$1.49$1.51-21.6%
2019$1.90$1.94-65.1%
2018$5.44$5.52+924.2%
2017$-0.66$-0.66-149.3%
2016$1.34$1.36-2.9%
2015$1.38$1.39+106.0%
2014$0.67$0.68-33.7%
2013$1.01$1.02+42.3%
2012$0.71$0.71-32.4%
2011$1.05$1.05+41.9%
2010$0.74$0.75-73.3%
2009$2.77$2.79

Annual Reports (10-K) · 10 filings

Report DateFiledAccession Number
2025-12-312026-02-110000310764-26-000010SEC ↗
2024-12-312025-02-120000310764-25-000023SEC ↗
2023-12-312024-02-140000310764-24-000024SEC ↗
2022-12-312023-02-100000310764-23-000017SEC ↗
2021-12-312022-02-110000310764-22-000028SEC ↗
2020-12-312021-02-110000310764-21-000027SEC ↗
2019-12-312020-02-060000310764-20-000014SEC ↗
2018-12-312019-02-070000310764-19-000014SEC ↗
2017-12-312018-02-080000310764-18-000031SEC ↗
2016-12-312017-02-090000310764-17-000034SEC ↗